A nephrology expert discusses survey findings that reveal gaps between UACR testing and action in cardiovascular risk assessment for type 2 diabetes.
Holly Kramer, MD, MPH
Advertisement
Holly Kramer, MD, MPH, is a Professor of Public Health Sciences and Medicine at Loyola University Chicago.
Articles by Holly Kramer, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Survey Finds Most PCPs Do Not Use uACR to Assess Cardiovascular Risk in Type 2 Diabetes
2
COVID-19 Vaccination Linked to Lower Risk of Severe Outcomes in Pregnancy Across Delta and Omicron Periods
3
FDA Accepts Supplemental Application for Teplizumab to Delay Stage 3 Type 1 Diabetes in Children Aged 1 Year and Older
4
Digital Screening Tool Duo Shows Promise for ADRD Detection in Primary Care: Daily Dose
5